Strong Evidence Supports the Use of Estradiol Therapy for the Treatment of Vaginal Inflammation: a Two-way Mendelian Randomization Study

Overview

Journal Eur J Med Res

Publisher Biomed Central

Specialty General Medicine

Date 2024 Jun 18

PMID 38890725

Authors

Xiaosheng Xu

Yan Liu

Weiwei Feng

Jian Shen

Affiliations

Soon will be listed here.

Abstract

Objective: Nowadays, there has been limited Mendelian randomization (MR) research focusing on the causal relationship between estradiol and vaginitis. Therefore, this study conducted a two-way MR study to clarify the causal effect and related influencing factors between them.

Methods: All genetic datasets were obtained using publicly available summary statistics based on individuals of European ancestry from the IEU GWAS database. MR analysis was performed using MR-Egger, weighted median (WM) and inverse variance weighted (IVW) methods to assess the causal relationship between exposure and outcome and to validate the findings by comprehensively evaluating the effects of pleiotropic effects and outliers.

Results: MR analysis revealed no significant causal relationship between estradiol and vaginitis risk. There was a negative correlation between estradiol and age at menarche (IVW, OR: 0.9996, 95% CI: 0.9992-1.0000, P = 0.0295; WM, OR: 0.9995, 95% CI: 0.9993-0.9998, P = 0.0003), and there was a positive correlation between age at menarche and vaginitis (IVW, OR: 1.5108, 95% CI: 1.1474-2.0930, P = 0.0043; MR-Egger, OR: 2.5575, 95% CI: 1.7664-9.6580, P = 0.0013). Estradiol was negatively correlated with age at menopause (IVW, OR: 0.9872, 95% CI: 0.9786-0.9959, P = 0.0041). However, there was no causal relationship between age at menopause and vaginitis (P > 0.05). In addition, HPV E7 Type 16, HPV E7 Type 18, and Lactobacillus had no direct causal effects on estradiol and vaginitis (P > 0.05). Sensitivity analyses revealed no heterogeneity and horizontal pleiotropy.

Conclusion: When estrogen levels drop, it will lead to a later age of menarche, and a later age of menarche may increase the risk of vaginitis, highlighting that the longer the female reproductive tract receives estrogen stimulation, the stronger the defense ability is formed, and the prevalence of vaginitis is reduced. In conclusion, this study indirectly supports an association between reduced level of estrogen or short time of estrogen stimulation and increased risk of vaginitis.

References

Flores V, Pal L, Manson J . Hormone Therapy in Menopause: Concepts, Controversies, and Approach to Treatment. Endocr Rev. 2021; 42(6):720-752. DOI: 10.1210/endrev/bnab011. View

Lu Y, Liu P, Recker R, Deng H, Dvornyk V . TNFRSF11A and TNFSF11 are associated with age at menarche and natural menopause in white women. Menopause. 2010; 17(5):1048-54. PMC: 2939156. DOI: 10.1097/gme.0b013e3181d5d523. View

Burgess S, Thompson S . Interpreting findings from Mendelian randomization using the MR-Egger method. Eur J Epidemiol. 2017; 32(5):377-389. PMC: 5506233. DOI: 10.1007/s10654-017-0255-x. View

Pickar J . Emerging therapies for postmenopausal vaginal atrophy. Maturitas. 2013; 75(1):3-6. DOI: 10.1016/j.maturitas.2013.01.020. View

Smith B, Zolnik C, Usyk M, Chen Z, Kaiser K, Nucci-Sack A . Distinct Ecological Niche of Anal, Oral, and Cervical Mucosal Microbiomes in Adolescent Women. Yale J Biol Med. 2016; 89(3):277-284. PMC: 5045137. View

Ma H, Bernstein L, Pike M, Ursin G . Reproductive factors and breast cancer risk according to joint estrogen and progesterone receptor status: a meta-analysis of epidemiological studies. Breast Cancer Res. 2006; 8(4):R43. PMC: 1779465. DOI: 10.1186/bcr1525. View

Mishra G, Cooper R, Tom S, Kuh D . Early life circumstances and their impact on menarche and menopause. Womens Health (Lond). 2009; 5(2):175-90. PMC: 3287288. DOI: 10.2217/17455057.5.2.175. View

de Siqueira Barros B, Kuschnir M, Bloch K, Silva T . ERICA: age at menarche and its association with nutritional status. J Pediatr (Rio J). 2018; 95(1):106-111. DOI: 10.1016/j.jped.2017.12.004. View

Safary M, Hakimi S, Mobaraki-Asl N, Amiri P, Tvassoli H, Delazar A . Comparison of the Effects of Fenugreek Vaginal Cream and Ultra Low- Dose Estrogen on Atrophic Vaginitis. Curr Drug Deliv. 2020; 17(9):815-822. DOI: 10.2174/1567201817666200708112655. View

10.

Shen J, Song N, Williams C, Brown C, Yan Z, Xu C . Effects of low dose estrogen therapy on the vaginal microbiomes of women with atrophic vaginitis. Sci Rep. 2016; 6:24380. PMC: 4840317. DOI: 10.1038/srep24380. View

11.

Lawlor D, Harbord R, Sterne J, Timpson N, Davey Smith G . Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Stat Med. 2007; 27(8):1133-63. DOI: 10.1002/sim.3034. View

12.

Buck E, Lukas V, Rubin R . Effective Prevention of Recurrent UTIs With Vaginal Estrogen: Pearls for a Urological Approach to Genitourinary Syndrome of Menopause. Urology. 2020; 151:31-36. DOI: 10.1016/j.urology.2020.05.058. View

13.

Clarkson J, Boon W, Simpson E, Herbison A . Postnatal development of an estradiol-kisspeptin positive feedback mechanism implicated in puberty onset. Endocrinology. 2009; 150(7):3214-20. PMC: 2703539. DOI: 10.1210/en.2008-1733. View

14.

Chee W, Chew S, Than L . Vaginal microbiota and the potential of Lactobacillus derivatives in maintaining vaginal health. Microb Cell Fact. 2020; 19(1):203. PMC: 7648308. DOI: 10.1186/s12934-020-01464-4. View

15.

Sturdee D, Panay N . Recommendations for the management of postmenopausal vaginal atrophy. Climacteric. 2010; 13(6):509-22. DOI: 10.3109/13697137.2010.522875. View

16.

Busch A, Hagen C, Assens M, Main K, Almstrup K, Juul A . Differential Impact of Genetic Loci on Age at Thelarche and Menarche in Healthy Girls. J Clin Endocrinol Metab. 2017; 103(1):228-234. DOI: 10.1210/jc.2017-01860. View

17.

Dvornyk V, Long J, Liu P, Zhao L, Shen H, Recker R . Predictive factors for age at menopause in Caucasian females. Maturitas. 2005; 54(1):19-26. DOI: 10.1016/j.maturitas.2005.08.005. View

18.

Kelley C . Estrogen and its effect on vaginal atrophy in post-menopausal women. Urol Nurs. 2007; 27(1):40-5. View

19.

Lynch C . Vaginal estrogen therapy for the treatment of atrophic vaginitis. J Womens Health (Larchmt). 2009; 18(10):1595-606. DOI: 10.1089/jwh.2008.1281. View

20.

Bernstein L, Pike M, Ross R, Henderson B . Age at menarche and estrogen concentrations of adult women. Cancer Causes Control. 1991; 2(4):221-5. DOI: 10.1007/BF00052137. View